Brittany Arnold

729 total citations
15 papers, 427 citations indexed

About

Brittany Arnold is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Brittany Arnold has authored 15 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Brittany Arnold's work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (4 papers). Brittany Arnold is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (5 papers) and Breast Cancer Treatment Studies (4 papers). Brittany Arnold collaborates with scholars based in United States. Brittany Arnold's co-authors include Alice Y. Ho, Simon N. Powell, Beryl McCormick, Monica Morrow, Heather L. McArthur, Zhigang Zhang, Ayca Gucalp, Christopher A. Barker, Mark E. Robson and Tiffany A. Traina and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Brittany Arnold

12 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brittany Arnold United States	8	265	198	99	99	95	15	427
Akiko Ogiya Japan	12	199 0.8×	288 1.5×	175 1.8×	56 0.6×	122 1.3×	43	424
Shawn Steen United States	11	148 0.6×	99 0.5×	60 0.6×	45 0.5×	121 1.3×	22	334
Clarence Eng United States	8	130 0.5×	158 0.8×	55 0.6×	79 0.8×	49 0.5×	16	342
Takayuki Takahama Japan	14	265 1.0×	150 0.8×	65 0.7×	267 2.7×	52 0.5×	45	473
Yawara Funasako Japan	11	171 0.6×	158 0.8×	66 0.7×	106 1.1×	149 1.6×	18	399
Louis Bazire France	9	123 0.5×	131 0.7×	71 0.7×	85 0.9×	92 1.0×	24	344
Marina Kem United States	10	217 0.8×	48 0.2×	70 0.7×	118 1.2×	63 0.7×	18	418
F. Moffat United States	9	299 1.1×	87 0.4×	33 0.3×	61 0.6×	167 1.8×	14	482
Jonathan Derman France	6	300 1.1×	82 0.4×	60 0.6×	128 1.3×	69 0.7×	8	482
Lars Sivars Sweden	12	214 0.8×	138 0.7×	50 0.5×	39 0.4×	116 1.2×	17	468

Countries citing papers authored by Brittany Arnold

Since Specialization

Citations

This map shows the geographic impact of Brittany Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brittany Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brittany Arnold more than expected).

Fields of papers citing papers by Brittany Arnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brittany Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brittany Arnold. The network helps show where Brittany Arnold may publish in the future.

Co-authorship network of co-authors of Brittany Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Brittany Arnold. A scholar is included among the top collaborators of Brittany Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brittany Arnold. Brittany Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Arnold, Brittany & Lindsay Ferrara. (2024). "Your Turn!": Using Finger Pointing and PALM-UP Actions to Ask Questions in Norwegian Sign Language. Sign language studies. 24(3). 621–651.

Ho, Alice Y., Stephen L. Shiao, Jonathan Chen, et al.. (2024). PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer. Journal of Clinical Oncology. 42(36). 4282–4293. 6 indexed citations

McArthur, Heather L., Stephen L. Shiao, Scott Karlan, et al.. (2021). Abstract PS12-09: Pre-operative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC). Cancer Research. 81(4_Supplement). PS12–9. 5 indexed citations

McArthur, Heather L., Stephen L. Shiao, Scott Karlan, et al.. (2020). Abstract P3-09-09: Pre-operative pembrolizumab (pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC). Cancer Research. 80(4_Supplement). P3–9. 3 indexed citations

Ho, Alice Y., Christopher A. Barker, Brittany Arnold, et al.. (2019). A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer. Cancer. 126(4). 850–860. 141 indexed citations

McArthur, Heather L., Christopher A. Barker, Ayca Gucalp, et al.. (2018). A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC).. Journal of Clinical Oncology. 36(15_suppl). 1017–1017. 11 indexed citations

Ho, Alice Y., Zhigang Zhang, Brittany Arnold, et al.. (2018). A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation. International Journal of Radiation Oncology*Biology*Physics. 101(2). 325–333. 53 indexed citations

Gelblum, Daphna Y., Alice Y. Ho, Brittany Arnold, et al.. (2018). Reconstruction Failure Rates in Breast Cancer Patients with Two-Stage Expander/Implant Reconstruction Receiving Regional Nodal Irradiation with VMAT: Early Results of a Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 102(3). S43–S43.

McArthur, Heather L., Christopher A. Barker, Ayca Gucalp, et al.. (2018). A single-arm, phase II study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC).. Journal of Clinical Oncology. 36(5_suppl). 14–14. 17 indexed citations

10.

McArthur, Heather L., Christopher A. Barker, Ayca Gucalp, et al.. (2017). A single-arm, phase ii study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC). Annals of Oncology. 28. v79–v79. 13 indexed citations

11.

Ho, Alice Y., Christopher A. Barker, Ayca Gucalp, et al.. (2017). Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer.. Journal of Clinical Oncology. 35(7_suppl). 95–95.

12.

Ho, Alice Y., Kinjal Vora, Brittany Arnold, et al.. (2017). Prevalence and Impact of Variants of Uncertain Significance on Local Therapy Decision-Making in Newly Diagnosed Breast Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 99(2). E2–E2. 1 indexed citations

13.

Zumsteg, Zachary S., Monica Morrow, Brittany Arnold, et al.. (2013). Breast-Conserving Therapy Achieves Locoregional Outcomes Comparable to Mastectomy in Women with T1-2N0 Triple-Negative Breast Cancer. Annals of Surgical Oncology. 20(11). 3469–3476. 108 indexed citations

14.

Perez, Carmen A., Zachary S. Zumsteg, Gaorav P. Gupta, et al.. (2013). Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis. Breast Cancer Research and Treatment. 139(2). 497–506. 20 indexed citations

15.

Milgrom, Sarah A., Hiram S. Cody, Lee K. Tan, et al.. (2012). Characteristics and Outcomes of Sentinel Node–Positive Breast Cancer Patients after Total Mastectomy without Axillary-Specific Treatment. Annals of Surgical Oncology. 19(12). 3762–3770. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact